NCT05548426View on ClinicalTrials.gov

Linezolid for Syphilis Pilot Study

PHASE2RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 28, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

March 31, 2026

Conditions
Syphilis
Interventions
DRUG

Group B, Linezolid 10d

Oral Linezolid 600mg, taken twice a day for 10 days

DRUG

Group A, Penicillin

Standard of care benzathine penicillin G, one intramuscular injection, 2.4MU

Trial Locations (2)

39216

RECRUITING

Open Arms HealthCare Center, Jackson

60613

RECRUITING

Howard Brown Health, Chicago

All Listed Sponsors
collaborator

Universidad Peruana Cayetano Heredia

OTHER

collaborator

The University of Texas Health Science Center, Houston

OTHER

lead

University of Southern California

OTHER